Close
4

Seqens Seqens

X

Company profile for ActualEyes

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Provides development information of cell products for corneal endothelium treatment. One leading cause of vison loss due to corneal endothelial decompensation is Fuchs endothelial corneal dystrophy (FECD), which has a prevalence of 4% in the Caucasian population over 40 years of age. The usual treatment for FECD is corneal transplantation, but this procedure has associated problems, especially a shortage of donor corneas. Othe...
Provides development information of cell products for corneal endothelium treatment. One leading cause of vison loss due to corneal endothelial decompensation is Fuchs endothelial corneal dystrophy (FECD), which has a prevalence of 4% in the Caucasian population over 40 years of age. The usual treatment for FECD is corneal transplantation, but this procedure has associated problems, especially a shortage of donor corneas. Other issues include graft failure (at both early and late phases) and the difficulty of the surgical transplantation procedure.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
ActualEyes
japan Flag
Country
Country
Japan
Address
Address
1-D-egg 314 Jizodani Kodo Kyotanabe-city
Telephone
Telephone
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY